BISPHOSPHONATE-ASSOCIATED FEMORAL FRACTURE: IMPLICATIONS FOR MANAGEMENT

Studies carried out on individuals being treated long teen with bisphosphonates have provoked considerable interest and perplexity about the effect that these drugs have on boric turnover in the long run. In fact the experiences reported by numerous researchers tend to highlight how treatment with high closes of bisphosphonates over many years, of individuals with osteoporosis complicated by or secondary to neoplastic pathologies. causes a suppression of bone turnover that over time predisposes the bone to the accumulation of micro damage that can then result in complicated fractures. as in the case described here.